Professional Documents
Culture Documents
Surgical Infections
Surgical Infections
• Host-Response
o Macrophages, complement proteins, immunoglobulins, & polymorphonuclear
leukocytes (PMNs)
“Infection is defined by the
presence of microorganisms in
host tissue or blood stream.”
Beilman GJ, Dunn DL. Surgical Infections. In: Brunicardi FC (editor). Schwartz’s Principles of Surgery.
11th ed. New York: McGraw-Hill; 2019: 160
Infection
• Several possible outcomes may occur
subsequent to microbial invasion and
interaction with host defense
a) Eradication
b) Containment
c) Locoregional Infection
d) Systemic Infection
https://www.researchgate.net/profile/Trofor-
Antigona/publication/303129346/figure/fig5/AS:618484937535504
@1524469708536/Tuberculous-bacilli-acid-fast-bacilli-present-in-
large-quantities-within-the.png
Fungi
http://3.bp.blogspot.com/-QULP-
• Culture analysis
MwObgM/TfFYgo9VRNI/AAAAAAAAGis/OrQmJbJA1i0/s160
0/Candida%2B_albicans_Budding%2B_Cells.jpg
• Special Stains
• Potassium Hydroxide (KOH)
• India Ink
• Methenamine Silver
• Giemsa Stain https://drfungus.org/wp-
content/uploads/2017/02/013MIKE.jpg
• Nosocomial infections
• Opportunistic infections in
immunocompromised https://microbenotes.com/wp-
content/uploads/2020/04/Gram%E2%80%99s-stain-
Panel-A-and-India-ink-stain-Panel-B-revealed-abundant-
encapsulated-round-yeasts-with-some-budding-forms.-
1536x883.jpeg
Virus
• Difficult to culture
• Mostly occur in
immunocompromised patients
PREVENTION & TREATMENT
OF SURGICAL INFECTIONS
Prophylaxis
• Maneuvers to diminish the
presence of exogenous
and endogenous microbes
Principles •
•
Hair removal
Cleansed with alcohol-
based antiseptic agent
Antimicrobial therapy
Patient physiologic
management
• Drainage of purulent material
Appropriate Use
• Prophylaxis is limited to time
of Antimicrobial prior to and during the operative
procedure
Agents
• Prolonged procedures should be
given additional dose/s if drug
short half-life
• Empiric Therapy
• Monomicrobial Infections
• UTI – 3-5 days
• Pneumonia – 7-8 days
• Bacteremia – 7-14 days
• Least toxic, least expensive agent
to which the organism is most
sensitive should be selected
• Intra-Abdominal Infections
• Sepsis
• Resistant Organisms
• Blood-Borne Pathogens
Surgical Site Infection
• Infections of the tissues, organs, or
spaces exposed by surgeons during
invasive procedures
• 2 Types:
o Incisional
o Organ/space Infection
• Development Factors:
o Degree of microbial contamination of the
wound during surgery
o Duration of procedure
o Host Factors
Wound Classification
• Class I (Clean) • Class III (Contaminated)
o No infection is present o Open accidental wounds encountered
o No hollow viscus that contains early after injury, with extensive
microbe is entered introduction of bacteria in a normally
sterile area of the body
• Class II (Clean/Contaminated)
o Include those in which hollow viscus
with indigenous microflora is opened
under controlled circumstances
without spillage of contents
Wound Classification
• Class IV (Dirty)
o Traumatic wounds in which a
significant delay in treatment has
occurred and in which necrotic tissue
is present, those created in the
presence of overt infection as
evidenced by the presence of purulent
material and those created to access a
perforated viscus accompanied by a
high degree of contamination
Intra-Abdominal
Infections
• Microbial contamination of peritoneal
cavity
• “Peritonitis”
• Primary
• Secondary
https://www.ncbi.nlm.nih.gov/books/NBK526129/bin/IMG_5128.jpg
Primary Peritonitis
• Microbes invade the normally sterile confines of peritoneal
cavity via:
o Hematogenous spread
o Direct inoculation
• Invariably monomicrobial
• Possible causative agents
o Escherichia coli
o Klebsiella pneumoniae
o Streptococcus pneumoniae
• Treatment
o Antibiotics for 14-31 days
o Removal of indwelling devices
Secondary Peritonitis
• Occurs due to subsequent contamination of the peritoneal
cavity due to perforation or severe inflammation and infection
of an intra-abdominal organ
• Source Control
o Resect or repair diseased organ
o Debridement of necrotic tissue
o Administration of antimicrobial agents directed against
aerobes and anaerobes
• Most morbid form:
o Colonic perforation due to large number of microbes
present
Secondary Peritonitis
• Patients in whom standard therapy fails:
o Intra-abdominal abscess
o Postoperative peritonitis
o Tertiary (Persistent) peritonitis
• Treatment
o Surgical Interventions
o Antibiotics for 3-7 days
o Most practitioners leave the drainage catheter in situ until
o Clear cavity collapse has occurred
o No evidence of ongoing contamination
o Output is <10-20 mL/d
o Patient’s clinical condition has improved
Organ-Specific Infections
• Large abscess
o Percutaneous drainage with
parameters for antibiotic therapy
o Drain removal
https://lh3.googleusercontent.com/proxy/79ZnJgdRFXCM6gjIC4kKc3xn2J_8cnbGYXUcTcV
26skjA9MlMQ5B5NpTHiQVqcaIGymL5OyxutFAlbDq0jQlzvNLiYSDNtyueiItRGsk
Secondary Pancreatic Infections
• Occur in approximately 10-15% of patients who develop severe
pancreatitis with necrosis
• Care for patients with severe acute pancreatitis:
o Staging with dynamic, contrast-enhanced helical CT
• Video-Assisted Retroperitoneal
Drainage (VARD)
These infections can be
classified according to whether
or not surgical intervention is
required
• Antimicrobials:
o High-dose aqueous Penicillin G
Bacteremia
• Considered based on
urinalysis
• WBCs, Bacteria, (+)
leukocyte esterase
Postoperative • Risk Factors
UTI • Prolonged duration of
catheterization, female sex
• Treatment
• 3-5 days single antibiotic
• More likely infected with
drug-resistant pathogens
• Diagnosis:
Nosocomial • Purulent sputum, elevated
leukocyte count, fever, &
Pneumonia new chest X-ray
abnormalities
• Treatment
• Empirical therapy
• May be associated with
indwelling intravascular
catherization
• Risk Factors
Bacteremia • Prolonged duration of
catheterization, insertion
during emergency or non-
sterile conditions, and use
of multilumen catheters
• Mostly asymptomatic
• Catheter removal
• Purulence at exit site
• Severe sepsis syndrome
Bacteremia • Treatment
• Antibiotics 14-21 days
Sepsis
Innate genetic
component or acquired
due to mutation
Resistant
Organisms MRSA most commonly
occurs as hospital-
associated infection in
chronically ill patients
Extended spectrum β-
lactamase (ESBL)-
producing strains of
Enterobacteriaceae
Resistant vanA gene of
Emerging vancomycin-
resistance in S. aureus
Blood Borne-Pathogens
• Human Immunodeficiency Virus (HIV)
o Low risk of transmission from patient to surgeon
o Minimized by: (a) routine use of barriers, (b) immediate washing after contact
with blood or body fluids, and (c) careful handling and disposal of sharp
instruments
o Postexposure Prophylaxis
3-drug regimen within 72 hours
Francisella tularensis
(Tularemia)
Treatment: doxycycline &
criprofloxacin
Thank You!
Reference:
Beilman GJ, Dunn DL. Surgical Infections. In: Brunicardi FC
(editor). Schwartz’s Principles of Surgery. 11th ed. New York:
McGraw-Hill; 2019: 157-179
THE FUTURE BELONGS
TO THOSE WHO BELIEVE IN
THE BEAUTY OF
THEIR DREAMS.
Eleanor Roosevelt